Clinical Trial Update: Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of IW001 in idiopathic pulmonary fibrosis has completed; the update summarizes the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• IW001

Snippet

Sponsor: ImmuneWorks | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED